CLEC9A and melanoma: Moreover, a conjugate of WH peptide to the immunodominant OVA epitope administered simultaneously with murine CpG ODN as an adjuvant significantly enhanced the activation of OVA-specific CD8+ T cells by Clec9A+ DCs and decreased metastasis formation in a murine B16-OVA melanoma lung-metastasis model.